Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125238517 | 12523851 | 7 | F | 20160608 | 20160824 | 20160704 | 20160830 | EXP | DE-AMGEN-DEUSP2016085605 | AMGEN | 60.00 | YR | A | M | Y | 0.00000 | 20160830 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125238517 | 12523851 | 1 | PS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | 125031 | 6 | MG | UNKNOWN FORMULATION | |||||||
| 125238517 | 12523851 | 2 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | 125031 | 6 | MG | UNKNOWN FORMULATION | |||||||
| 125238517 | 12523851 | 3 | SS | pegfilgrastim | PEGFILGRASTIM | 1 | Subcutaneous | 6 MG, UNK | 125031 | 6 | MG | UNKNOWN FORMULATION | |||||||
| 125238517 | 12523851 | 4 | SS | RITUXIMAB | RITUXIMAB | 1 | Subcutaneous | 1400 MG, Q3WK | 0 | 1400 | MG | INJECTION | Q3W | ||||||
| 125238517 | 12523851 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Subcutaneous | 1400 MG, UNK | 0 | 1400 | MG | INJECTION | |||||||
| 125238517 | 12523851 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1215 MG, UNK | 0 | 1215 | MG | ||||||||
| 125238517 | 12523851 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 750 MG/M2, UNK | 0 | 750 | MG/M**2 | ||||||||
| 125238517 | 12523851 | 8 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 81 MG, UNK | 0 | 81 | MG | ||||||||
| 125238517 | 12523851 | 9 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 50 MG/M2, UNK | 0 | 50 | MG/M**2 | ||||||||
| 125238517 | 12523851 | 10 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG, UNK | 0 | 2 | MG | ||||||||
| 125238517 | 12523851 | 11 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1 MG/M2, UNK | 0 | 1 | MG/M**2 | ||||||||
| 125238517 | 12523851 | 12 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 100 MG, 1 IN 1 D | 500 | MG | 0 | 100 | MG | QD | |||||
| 125238517 | 12523851 | 13 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 7.5 MG, UNK | 500 | MG | 0 | 7.5 | MG | ||||||
| 125238517 | 12523851 | 14 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 100 MG, UNK | 500 | MG | 0 | 100 | MG | ||||||
| 125238517 | 12523851 | 15 | SS | COTRIM FORTE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 860 MG, UNK | 0 | 860 | MG | ||||||||
| 125238517 | 12523851 | 16 | SS | COTRIM FORTE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 960 MG, UNK | 0 | 960 | MG | ||||||||
| 125238517 | 12523851 | 17 | SS | ACIC | ACYCLOVIR | 1 | Oral | 800 MG, UNK | 0 | 800 | MG | ||||||||
| 125238517 | 12523851 | 18 | SS | ACIC | ACYCLOVIR | 1 | Oral | 400 MG, UNK | 0 | 400 | MG | ||||||||
| 125238517 | 12523851 | 19 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 3.5 MG, UNK | 0 | 3.5 | MG | |||||||||
| 125238517 | 12523851 | 20 | C | CYCLOSPORIN A | CYCLOSPORINE | 1 | UNK | 0 | |||||||||||
| 125238517 | 12523851 | 21 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 1 G, UNK | 0 | 1 | G | |||||||||
| 125238517 | 12523851 | 22 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | UNK | 0 | |||||||||||
| 125238517 | 12523851 | 23 | C | METOPROLOL. | METOPROLOL | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 125238517 | 12523851 | 24 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | 0 | |||||||||||
| 125238517 | 12523851 | 25 | C | ASPIRIN. | ASPIRIN | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 125238517 | 12523851 | 26 | C | OMEPRAZOL | OMEPRAZOLE | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 125238517 | 12523851 | 27 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | 2 G, UNK | 0 | 2 | G | |||||||||
| 125238517 | 12523851 | 28 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 300 G, DAY | 0 | 300 | G | QD | ||||||||
| 125238517 | 12523851 | 29 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 125238517 | 12523851 | 30 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | 475 MG, UNK | 0 | 475 | MG | |||||||||
| 125238517 | 12523851 | 31 | C | VIGANTOLETTEN | CHOLECALCIFEROL | 1 | 2000 IU, QD | 0 | 2000 | IU | QD | ||||||||
| 125238517 | 12523851 | 32 | C | TACROLIMUS. | TACROLIMUS | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125238517 | 12523851 | 1 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 4 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 6 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 8 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 10 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 12 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 15 | Post transplant lymphoproliferative disorder |
| 125238517 | 12523851 | 17 | Post transplant lymphoproliferative disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125238517 | 12523851 | OT |
| 125238517 | 12523851 | HO |
| 125238517 | 12523851 | DE |
| 125238517 | 12523851 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125238517 | 12523851 | Arthritis | |
| 125238517 | 12523851 | Cerebrovascular accident | |
| 125238517 | 12523851 | Death | |
| 125238517 | 12523851 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125238517 | 12523851 | 1 | 20160604 | 20160604 | 0 | |
| 125238517 | 12523851 | 2 | 20160620 | 20160625 | 0 | |
| 125238517 | 12523851 | 3 | 20160716 | 20160716 | 0 | |
| 125238517 | 12523851 | 4 | 20160412 | 0 | ||
| 125238517 | 12523851 | 5 | 20160622 | 20160622 | 0 | |
| 125238517 | 12523851 | 6 | 20160601 | 20160601 | 0 | |
| 125238517 | 12523851 | 7 | 20160622 | 20160622 | 0 | |
| 125238517 | 12523851 | 8 | 20160601 | 20160601 | 0 | |
| 125238517 | 12523851 | 9 | 20160622 | 20160622 | 0 | |
| 125238517 | 12523851 | 10 | 20160601 | 20160601 | 0 | |
| 125238517 | 12523851 | 11 | 20160622 | 20160622 | 0 | |
| 125238517 | 12523851 | 12 | 20160601 | 20160605 | 0 | |
| 125238517 | 12523851 | 14 | 20160622 | 20160626 | 0 | |
| 125238517 | 12523851 | 15 | 20160528 | 0 | ||
| 125238517 | 12523851 | 16 | 20160628 | 0 | ||
| 125238517 | 12523851 | 17 | 20160601 | 0 | ||
| 125238517 | 12523851 | 18 | 20160601 | 0 | ||
| 125238517 | 12523851 | 19 | 200403 | 0 | ||
| 125238517 | 12523851 | 21 | 200403 | 0 |